US Patent No. 8,969,001

Materials and methods for predicting recurrence of non-small cell lung cancer
Mar 09, 2015

Rush University Medical Center has been awarded US Patent No. 8,969,001, "Materials and methods for predicting recurrence of non-small cell lung cancer."

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.